Publications by authors named "Martyn Caplin"

100Publications

Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs).

Lung Cancer 2020 Oct 14;150:70-75. Epub 2020 Oct 14.

Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.10.005DOI Listing
October 2020

Features of carcinoid heart disease identified by cardiac computed tomography.

J Cardiovasc Comput Tomogr 2020 Sep 6. Epub 2020 Sep 6.

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcct.2020.08.009DOI Listing
September 2020

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy.

Lancet Oncol 2020 09;21(9):e431-e443

Department of Surgery, Yale University School of Medicine, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(20)30323-5DOI Listing
September 2020

Home Total Parenteral Nutrition for Intestinal Failure in Patients with Advanced Small Intestinal Neuroendocrine Neoplasms.

Nutr Cancer 2020 Aug 31:1-6. Epub 2020 Aug 31.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2020.1810713DOI Listing
August 2020

The impact of Ga-68 DOTATATE PET/CT imaging on management of patients with paragangliomas.

Nucl Med Commun 2020 Feb;41(2):169-174

Institute of Nuclear Medicine, University College London Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000001130DOI Listing
February 2020

Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes.

Endocrine 2020 02 15;67(2):485-493. Epub 2019 Nov 15.

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, Pond Street, London, NW3 2QG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12020-019-02130-5DOI Listing
February 2020

Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors.

Endosc Int Open 2019 Nov 22;7(11):E1393-E1399. Epub 2019 Oct 22.

Department of Gastroenterology, University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0967-4684DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805236PMC
November 2019

Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.

Pancreas 2019 08;48(7):934-942

Centre for Gastroenterology, Neuroendocrine Tumor Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000001347DOI Listing
August 2019

Challenging the Current Risk Factors of Appendiceal Neuroendocrine Neoplasms: Can They Accurately Predict Local Lymph Nodal Invasion? Results from a Large Case Series.

Neuroendocrinology 2019 6;109(2):179-186. Epub 2019 May 6.

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000499381DOI Listing
June 2020

Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3).

Neuroendocrinology 2019 28;108(1):54-62. Epub 2018 Aug 28.

Oncology Department, Hospital Universitario 12 de Octubre, CNIO, CIBERONC, Universidad Complutense de Madrid, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000493318DOI Listing
December 2019

Carcinoid Heart Disease: A Review.

Endocrinol Metab Clin North Am 2018 09;47(3):671-682

Neuroendocrine Tumour Unit, Royal Free Hospital, Pond Street, London NW3 2QG, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2018.04.012DOI Listing
September 2018

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With Lu-Dotatate in the Phase III NETTER-1 Trial.

J Clin Oncol 2018 09 7;36(25):2578-2584. Epub 2018 Jun 7.

Jonathan Strosberg, Moffitt Cancer Center, Tampa, FL; Edward Wolin, Montefiore Einstein Center for Cancer Care, Bronx, NY; Beth Chasen, University of Texas MD Anderson Cancer Center, Houston, TX; Matthew Kulke, Dana-Farber Cancer Institute, Boston, MA; David Bushnell, University of Iowa, Iowa City, IA; Martyn Caplin, Royal Free Hospital, London, United Kingdom; Richard P. Baum, Zentralklinik, Bad Berka, Germany; Pamela Kunz, Stanford University Medical Center, Stanford; Andrew Hendifar, Cedars Sinai Medical Center, Los Angeles, CA; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Kjell Oberg, University Hospital, Uppsala University, Uppsala, Sweden; Maribel Lopera Sierra, Thomas Thevenet, and Ines Margalet, Advanced Accelerator Applications, Geneva, Switzerland; Philippe Ruszniewski, Hopital Beaujon and Paris Diderot University, Clichy, France; and Eric Krenning, Erasmus Medical Center, Rotterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.5865DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366953PMC
September 2018

Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours.

Eur J Surg Oncol 2019 01 22;45(1):52-59. Epub 2018 Mar 22.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07487983183096
Publisher Site
http://dx.doi.org/10.1016/j.ejso.2018.03.012DOI Listing
January 2019

Prognostic Factors for Survival among Patients with Small Bowel Neuroendocrine Tumours Associated with Mesenteric Desmoplasia.

Neuroendocrinology 2018 10;106(4):366-380. Epub 2018 Jan 10.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, ENETS Centre of Excellence, Royal Free London NHS Foundation Trust, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486097DOI Listing
January 2019

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours.

Eur J Surg Oncol 2019 01 16;45(1):46-51. Epub 2017 Oct 16.

Department of Hepato-Pancreato-Biliary Surgery & Liver Transplantation, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2017.08.019DOI Listing
January 2019

Neuroendocrine tumors and fibrosis: An unsolved mystery?

Cancer 2017 Dec 7;123(24):4770-4790. Epub 2017 Nov 7.

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31079DOI Listing
December 2017

Early efficacy of and toxicity from lutetium-177-DOTATATE treatment in patients with progressive metastatic NET.

Nucl Med Commun 2017 Jul;38(7):593-600

Departments of aNuclear Medicine bGastroenterology and Neuroendocrine Tumours, Royal Free Hospital cSchool of Public Health, Faculty of Medicine, Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000685DOI Listing
July 2017

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas.

J Surg Oncol 2017 Mar 6;115(4):425-434. Epub 2017 Feb 6.

ENETS Centre of Excellence Neuroendocrine Tumour Unit, Royal Free London NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24553DOI Listing
March 2017

Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.

N Engl J Med 2017 01;376(2):125-135

From the Moffitt Cancer Center, Tampa, FL (J.S., G.E.-H.); Markey Cancer Center, University of Kentucky, Lexington (E.W.); Cedars Sinai Medical Center, Los Angeles (A.H.), and Stanford University School of Medicine, Stanford (E.M., P.L.K.) - both in California; University of Texas M.D. Anderson Cancer Center (J.Y., B.C.) and Excel Diagnostics Imaging Clinic (E.D.), Houston; Dana-Farber Cancer Institute, Boston (M.H.K., H.J.); University of Iowa, Iowa City (D.B., T.M.O.); Zentralklinik, Bad Berka (R.P.B., H.R.K.), and Charité-Universitätsmedizin, Berlin (M.P.) - both in Germany; Royal Free Hospital (M.C.) and King's College Hospital NHS Foundation Trust (R.S.), London, and Beatson Oncology Centre, Glasgow (N.R.) - all in the United Kingdom; Hôpital Beaujon, Clichy (R.L., P.R.), and Advanced Accelerator Applications, St. Genis-Pouilly (T.T.) - both in France; Mayo Clinic College of Medicine, Rochester, MN (T.H.); University Hospitals and KU Leuven, Leuven, Belgium (E.V.C.); Robert H. Lurie Comprehensive Cancer Center, Chicago (A.B.); Hospital Universitari de Bellvitge, Barcelona (J.M.), and Hospital Universitario Ramón y Cajal, Madrid (E.G.) - both in Spain; Vanderbilt University Medical Center, Nashville (J.B.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan (E.S.); University Hospital, Uppsala University, Uppsala, Sweden (K.O.); Advanced Accelerator Applications USA, New York (M.L.S., P.S., J.L.E.); and Erasmus Medical Center, Rotterdam, the Netherlands (D.K., E.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1607427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895095PMC
January 2017

Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.

Clin Respir J 2018 Mar 17;12(3):904-914. Epub 2017 Jan 17.

Neuroendocrine Tumour Unit, European (ENETS) Centre of Excellence, Royal Free Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/crj.12603DOI Listing
March 2018

The Impact of Radiological Response to Peptide Receptor Radionuclide Therapy on Overall Survival in Patients With Metastatic Midgut Neuroendocrine Tumors.

Clin Nucl Med 2017 Mar;42(3):e135-e141

From the *Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London; †Care of the Elderly, University College Hospital, London; ‡Nuclear Medicine Department, Royal Free Hospital, London; and §Faculty of Medicine, St Mary's Campus, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00003072-201703000-0003
Publisher Site
http://dx.doi.org/10.1097/RLU.0000000000001457DOI Listing
March 2017

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome.

J Clin Oncol 2017 Jan 28;35(1):14-23. Epub 2016 Oct 28.

Matthew H. Kulke, Dana-Farber Cancer Institute, Boston; Douglas Fleming, Ipsen Bioscience, Cambridge, MA; Dieter Hörsch, Zentralklinik Bad Berka, Bad Berka; Marianne Pavel, Charité-Universitätsmedizin, Berlin, Germany; Martyn E. Caplin, Royal Free Hospital, London; Juan W. Valle, The University of Manchester-The Christie National Health Service Foundation Trust, Manchester, United Kingdom; Lowell B. Anthony, University of Kentucky, Lexington, KY; Emily Bergsland, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Pamela L. Kunz, Stanford University, Palo Alto, CA; Kjell Öberg and Staffan Welin, Uppsala University, Uppsala, Sweden; Richard R.P. Warner, Icahn School of Medicine at Mount Sinai, New York, NY; Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Pablo Lapuerta, Phillip Banks, Shanna Jackson, Brian Zambrowicz, and Arthur T. Sands, Lexicon Pharmaceuticals, The Woodlands, TX; and Enrique Grande, Hospital Universitario Ramón y Cajal, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.2780DOI Listing
January 2017

Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours.

Br J Cancer 2016 Nov 3;115(11):1321-1327. Epub 2016 Nov 3.

Centre for Gastroenterology, Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital NHS Foundation Trust, London NW3 2QG, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/bjc2016349
Publisher Site
http://dx.doi.org/10.1038/bjc.2016.349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129835PMC
November 2016

The role of dietary supplements in inflammatory bowel disease: a systematic review.

Eur J Gastroenterol Hepatol 2016 Dec;28(12):1357-1364

aGastroenterology and Endoscopy Unit-Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, ItalybDepartment of Nutrition & Dietetics, Centre of GastroenterologycCentre for Gastroenterology, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000000728DOI Listing
December 2016

Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study.

Endocr Relat Cancer 2016 Mar 7;23(3):191-9. Epub 2016 Jan 7.

Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740728PMC
March 2016

ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update.

Neuroendocrinology 2016 6;103(2):117-8. Epub 2016 Jan 6.

NET Centre St. Vincent's University and Department of Clinical Medicine St. James Hospital and Trinity College, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://www.klinikum.uni-muenchen.de/NET-Zentrum/download/inh
Web Search
http://www.karger.com/?doi=10.1159/000443169
Publisher Site
http://dx.doi.org/10.1159/000443169DOI Listing
December 2016

Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.

Asia Pac J Clin Oncol 2016 Mar 14;12(1):61-9. Epub 2015 Dec 14.

Neuroendocrine Tumour Unit, ENETS Centre of Excellence.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12438DOI Listing
March 2016

Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.

J Surg Oncol 2015 Oct 4;112(5):486-91. Epub 2015 Sep 4.

Centre for Endocrine Surgery, University College London Hospital and Great Ormond Street Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.24030DOI Listing
October 2015

Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours.

Ann Transl Med 2015 Jun;3(9):118

1 Neuroendocrine Tumour Unit, Centre of Gastroenterology, Royal Free Hospital, London, UK ; 2 Gastroenterology and Endoscopy Unit Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico and Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy ; 3 Cancer Institute, University College London, London, UK ; 4 Department of Histopathology, 5 Department of Clinical Biochemistry, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.04.23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481369PMC
June 2015

Roles of miR-196a on gene regulation of neuroendocrine tumor cells.

Mol Cell Endocrinol 2015 Sep 4;412:131-9. Epub 2015 Jun 4.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory,Endocrine Oncology Clinic, Uppsala University Hospital, Uppsala, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2015.06.003DOI Listing
September 2015

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.

PLoS One 2015 5;10(5):e0125553. Epub 2015 May 5.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Endocrine Oncology Clinic, Uppsala University Hospital, Science for Life Laboratory, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125553PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420277PMC
February 2016

Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours.

Endocr Relat Cancer 2015 Jun 21;22(3):L13-8. Epub 2015 Apr 21.

Medical Genomics Laboratory, University College London Cancer Institute, University College London72 Huntley Street, London, WC1E 6BT, UK Medical Genomics Laboratory, University College London Cancer Institute, University College London72 Huntley Street, London, WC1E 6BT, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496774PMC
June 2015

Goblet cell appendiceal tumors--management dilemmas and long-term outcomes.

Surg Oncol 2015 Mar 28;24(1):47-53. Epub 2015 Jan 28.

Neuroendocrine Tumor Unit, Centre of Gastroenterology, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2015.01.001DOI Listing
March 2015

Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.

J Clin Endocrinol Metab 2015 Apr 30;100(4):1511-9. Epub 2015 Jan 30.

Charité - Universitätsmedizin (M.P., B.W.), Department of Gastroenterology and Hepatology, 13353 Berlin Germany; Zentralklinik Bad Berka GmbH (D.H.), Department of Gastroenterology and Endocrinology, 99437 Bad Berka, Germany; Royal Free London National Health Service (NHS) Foundation Trust (M.C.), Department of Gastroenterology and Hepatobiliary Medicine, London NW3 2QG, United Kingdom; Basingstoke and North Hampshire NHS Foundation Trust (J.R.), Department of Gastroenterology, Hampshire RG24 9NA, United Kingdom; Ulm University (T.S.), Department of Internal Medicine I, 89070 Ulm, Germany; The University of Manchester/The Christie NHS Foundation Trust (J.V.), Department of Medical Oncology, Manchester M20 4BX, United Kingdom; and Lexicon Pharmaceuticals, Inc (P.B., P.L., A.S., B.Z., D.F.), Department of Clinical Development, The Woodlands, Texas 77381.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2014-2247DOI Listing
April 2015

The role of dietary factors in prevention and progression of breast cancer.

Anticancer Res 2014 Dec;34(12):6861-75

Centre for Gastroenterology, Royal Free Hospital, London, U.K.

View Article

Download full-text PDF

Source
http://ar.iiarjournals.org/content/34/12/6861.full.pdf
Web Search
December 2014

Role of interferon-alpha in patients with neuroendocrine tumors: a retrospective study.

Anticancer Res 2014 Nov;34(11):6601-7

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, U.K.

View Article

Download full-text PDF

Source
November 2014

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

N Engl J Med 2014 Jul;371(3):224-33

From Royal Free Hospital, London (M.E.C.); Charité University Medicine Berlin, Berlin (M.P.); University of Warmia and Mazury, Olsztyn, Poland (J.B.Ć.); University of Texas M.D. Anderson Cancer Center, Houston (A.T.P.); University Hospital, Vienna (M.R.); Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic (E.S.); Robert-Debré Hospital, Reims (G.C.), Ipsen, Les Ulis, (A.L., S.M., J.B.), Beaujon Hospital, Clichy (P.R.), and Paris Diderot University, Paris (P.R.) - all in France; Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles (E.M.W.); Vall d'Hebron University Hospital, Barcelona (J.C.); Western General Hospital, Edinburgh (L.W.); and Università Cattolica del Sacro Cuore, Rome (G.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1316158DOI Listing
July 2014

Prostate cancer and the influence of dietary factors and supplements: a systematic review.

Nutr Metab (Lond) 2014 16;11:30. Epub 2014 Jun 16.

Centre for Gastroenterology, Royal Free Hospital, Pond Street, London NW3 2QG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1743-7075-11-30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073189PMC
June 2014

The impact of diet and nutrition in the prevention and progression of hepatocellular carcinoma.

Expert Rev Gastroenterol Hepatol 2014 May 6;8(4):369-82. Epub 2014 Mar 6.

Centre for Gastroenterology, Royal Free Hospital, Pond Street, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474124.2014.894879DOI Listing
May 2014

Liver transplantation for unresectable neuroendocrine tumor liver metastases.

Ann Surg Oncol 2014 Jul 22;21(7):2398-405. Epub 2014 Feb 22.

Neuroendocrine Tumour Unit, Centre of Gastroenterology, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3523-yDOI Listing
July 2014

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

Eur J Cancer 2014 Mar 17;50(5):902-11. Epub 2014 Jan 17.

Cambridge Cancer Trials Centre, Cambridge Clinical Trials Unit - Cancer Theme, Addenbrooke's Hospital, Cambridge, UK; Oncology Centre, Addenbrooke's Hospital, Cambridge, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.12.011DOI Listing
March 2014

Nutrition and pancreatic cancer.

Anticancer Res 2014 Jan;34(1):9-21

Department of Gastroenterology, Royal Free Hospital, Pond Street, London, NW3 2QG, U.K.

View Article

Download full-text PDF

Source
January 2014

Diet and supplements and their impact on colorectal cancer.

J Gastrointest Oncol 2013 Dec;4(4):409-23

Centre for Gastroenterology, Royal Free Hospital, London, NW3 2QG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2078-6891.2013.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819783PMC
December 2013

The use of biomarkers in neuroendocrine tumours.

Frontline Gastroenterol 2013 Jul 21;4(3):175-181. Epub 2013 Mar 21.

UCL Cancer Institute, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/flgastro-2012-100272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369797PMC
July 2013

Colonic and rectal NET's.

Best Pract Res Clin Gastroenterol 2012 Dec;26(6):775-89

Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bpg.2013.01.007DOI Listing
December 2012

Update on the role of somatostatin analogs for the treatment of patients with gastroenteropancreatic neuroendocrine tumors.

Semin Oncol 2013 Feb;40(1):56-68

Neuroendocrine Tumour Unit, ENETS Centre of Excellence, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00937754120020
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2012.11.006DOI Listing
February 2013

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.

J Nucl Med 2013 Mar 7;54(3):364-72. Epub 2013 Jan 7.

Institute of Nuclear Medicine, University College Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.112.111724DOI Listing
March 2013

Circulating tumor cells as prognostic markers in neuroendocrine tumors.

J Clin Oncol 2013 Jan 17;31(3):365-72. Epub 2012 Dec 17.

University College London (UCL) Cancer Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/31/3/365.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2012.44.2905
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.44.2905DOI Listing
January 2013

Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature.

Case Rep Oncol 2012 May 12;5(2):313-9. Epub 2012 Jun 12.

Department of Neuroendocrine Tumours, European Center of Excellence, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000339611DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383252PMC
May 2012

Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?

Endocr Relat Cancer 2012 Jun 24;19(3):R73-92. Epub 2012 May 24.

University College London Cancer Institute, Paul O'Gorman Building, Huntley Street, London WC1E 6BT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-12-0050DOI Listing
June 2012

mTOR inhibitor therapy for patients with carcinoid.

Lancet 2011 Dec 25;378(9808):1978-1980. Epub 2011 Nov 25.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)61789-3DOI Listing
December 2011

Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.

Endocr Relat Cancer 2011 Oct 17;18 Suppl 1:S53-74. Epub 2011 Oct 17.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, London NW3 2QG, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-10-0271DOI Listing
October 2011

Risk factors for the development and progression of carcinoid heart disease.

Am J Cardiol 2011 Apr 4;107(8):1221-6. Epub 2011 Feb 4.

Carcinoid Heart Disease Clinic, Department of Cardiology, Royal Free Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2010.12.025DOI Listing
April 2011

Circulating tumor cells and EpCAM expression in neuroendocrine tumors.

Clin Cancer Res 2011 Jan 11;17(2):337-45. Epub 2011 Jan 11.

Neuroendocrine Tumour Unit, Centre for Gastroenterology, Royal Free Hospital, UCL Cancer Institute, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1776DOI Listing
January 2011

Outcomes, risks and complications of cardiac surgery for carcinoid heart disease.

Eur J Cardiothorac Surg 2011 Jul 14;40(1):168-72. Epub 2010 Dec 14.

Department of Cardiology, Royal Free Hospital, Pond Street, London NW3 2QG, UK.

View Article

Download full-text PDF

Source
https://academic.oup.com/ejcts/article-lookup/doi/10.1016/j.
Publisher Site
http://dx.doi.org/10.1016/j.ejcts.2010.10.035DOI Listing
July 2011